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Infection of microglial cells by the human immunodeficiency virus (HIV) is supposed to play an important role in the
pathogenesis of AIDS-related central nervous system (CNS) complications. So far, however, experimental data about
interactions between HIV and ramified microglia from the adult CNS were only occasionally reported, making it difficult to
understand the exact nature of pathogenic events contributing to HIV-encephalopathy. Therefore, we used the animal model
of feline immunodeficiency virus (FIV) infection of domestic cats to establish an experimental system which is suitable for
studying the relationships between an immunodeficiency virus and the mature ramified microglia of the central nervous
system. By means of density gradient centrifugation approximately 95% pure microglial cells could be isolated from adult
feline brain that were characterized by their CD45low phenotype. Resident microglia extracted from the CNS of experimentally
infected cats harbored FIV-specific DNA and cocultivation with mitogen-activated, but uninfected peripheral blood mononu-
clear cells (PBMC) resulted in recovery of high-titered infectious virus. Double labeling of brain cell monocultures explanted
from persistently infected animals for both microglia and FIV markers disclosed less than 1% of viral antigen expressing
microglial cells. This suggests that during the subclinical phase of the infection only a small number of brain-resident
macrophages are productively infected. However, interaction of FIV-infected microglia and inflammatory lymphocytes may
promote viral replication, thus supporting viral spread in brain tissue. © 2000 Academic PressKey Words: FIV; lentivirus; encephalopathy; microglia.
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HIV-infection of the CNS frequently leads to severe
motor and/or cognitive impairments, collectively termed
HIV-encephalopathy. Pathological hallmarks of this CNS
disorder are a multinucleated giant cell (MGC) enceph-
alitis, astrocytosis, and vacuolar myelopathy (Budka et
al., 1987; Navia et al., 1986). In addition, extensive neu-
ronal injury and loss may occur preferentially during later
stages of HIV disease (Ketzler et al., 1990; Lipton and
Gendelman, 1995; Wiley et al., 1991). Although there are
ome reports indicating occasional lentiviral infection of
eurons as well as astrocytes, oligodendrocytes, and
rain endothelial cells (Moses et al., 1993; Nuovo et al.,
994; Saito et al., 1994; Tornatore et al., 1994), microglial
ells are believed to be the preferential target for HIV in
rain parenchyma (Koenig et al., 1986; Wiley et al., 1986).
n view of the discrepancy between selective localization
f virus to the tissue-resident macrophage population
nd substantial neuropathology, there is emerging con-
ensus that virus-induced but indirect pathogenic mech-
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420nisms are responsible for CNS dysfunction. Possible
actors that may contribute to HIV-associated dementia
nclude alterations in nerve cell physiology and immuno-
hemical microenvironment that may result from soluble
ediators as quinolinic acid (Heyes et al., 1989), cyto-
ines (Merrill and Chen, 1991; Soliven and Albert, 1992),
itric oxide (Lipton et al., 1993), and viral proteins (Bren-
eman et al., 1988; Sabatier et al., 1991). All of these
ubstances may be released from HIV-infected micro-
lia, implying an important role of brain-resident macro-
hages in HIV encephalopathy. Detailed analysis of re-
ations between lentiviral CNS-infection and microglial
ell function may therefore advance current understand-
ng of the pathogenic mechanisms underlying the neu-
ological and neurobehavioral complications of neuro-
IDS. However, studies on HIV-induced neuropathogen-
sis are complicated by several obstacles mainly due to
he limited availability of well preserved CNS material
rom both HIV-infected and normal individuals. Also, iso-
ation of tissue-resident macrophages especially from
dult brain parenchyma is experimentally difficult to
chieve and it is only recently that this problem has been
vercome (Sedgwick et al., 1991). Therefore, most of the
ata published so far on the interactions between lenti-
iral infection and CNS-derived macrophages originates
rom in vitro studies performed with microglial cells from
mbryonic or neonatal brain (Dickson et al., 1991; Dow et
l., 1992; Peudenier et al., 1991). As CNS evolution at time
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421FIV INFECTION OF FELINE RAMIFIED MICROGLIAof birth is morphologically not accomplished cells ex-
tracted thereof may not represent ramified microglia but
a mixture of resident and blood-derived monocytes/mac-
rophages of variable differentiation. Thus, fetal CNS cell
populations can hardly reflect the physiological and
functional properties of adult resident microglial cells.
To more precisely assess the events taking place in
mature brain tissue during lentiviral induced CNS dis-
ease we used the animal model of feline immunodefi-
ciency virus infection of domestic cats which exhibits
pathology similar to human AIDS including lentiviral in-
duced encephalopathy (Henriksen et al., 1995; Pedersen
et al., 1987; Podell et al., 1993). Primary cellular targets of
FIV in the brain seem to be tissue-resident microglial
cells as well as astrocytes that both have been shown to
support retroviral replication in vitro (Dow et al., 1992).
hese data, however, have been obtained using neona-
al CNS cell populations that may differ in susceptibility
nd/or permissiveness to retroviral infection compared
o fully differentiated brain cells. In this report, we de-
cribe isolation and phenotypic characterization of ram-
fied microglial cells from adult cat brain. Comparable to
revious findings in rodents (Sedgwick et al., 1991) and
onhuman primates (Brinkmann et al., 1993) feline mi-
croglial cells can be distinguished from CNS-infiltrating
monocytes by differential expression of the leukocyte
common antigen (LCA). In addition, microglia may harbor
FIV gene sequences in vivo and promote productive viral
replication in vitro following explantation from infected
animals. The data presented emphasize brain-resident
macrophages as important target cells for central ner-
vous FIV infection.
RESULTS
Phenotypic characterization of adult feline microglial
cells
CNS cells were isolated from persistently FIV-infected
and uninfected cats applying Percoll gradient centrifuga-
tion that has previously been shown to yield in pure
microglial cells (Sedgwick et al., 1991). Total number of
cells recoverable by the gradient technique used here
fell in the range 2.26 3 107 6 0.55 3 107 SEM cells per
CNS. Within the brain-extracted cell population micro-
glial cells were identified by immunostaining with mono-
clonal antibodies and subsequent FACS analysis. Con-
sistent with recent findings in rodents (Sedgwick et al.,
1991) brain-resident macrophages could be character-
ized as CD45low compared to broncho-alveolar macro-
phages that displayed a CD45medium phenotype and
pleenocytes which were CD45high (Fig. 1). Leukocyte
common antigen expression could therefore be used to
distinguish microglia from other bone marrow-derived
hemopoetic cells. Routinely, more than 95% of CNS-
isolated cells were CD45low (data not shown).
In order to further characterize the CD45low population,
ells isolated from brain parenchyma were subjected towo-color flow cytometry. As summarized in Fig. 2, nor-
al feline microglia expressed CD9, CD18, and CD45 but
ot CD4, CD5, CD8, or CD40. Besides, both classes of
HC antigens were detectable although the level of
HC class I expression was low (Fig. 2). In culture,
icroglial cells changed morphology from ramified to
meboid with short cell processes within a few days.
hey stained positive for the low density lipoprotein
LDL) receptor that is restricted to microglia and vascular
ndothelium in the CNS (Christie et al., 1996; Me`resse et
l., 1989) (Fig. 3A). In contrast, glial fibrillary acidic pro-
ein (GFAP) and galactocerebroside (Gal C) expression
as absent (data not shown).
solation of microglia-derived FIV from experimentally
nfected cats
In an earlier report it has been documented that mi-
roglial cells from neonatal feline brain tissue are a
referential target for FIV (Dow et al., 1992). In view of
hese studies, we investigated retroviral infection of the
NS-resident macrophage population following extrac-
ion from experimentally FIV-infected adult cats. Employ-
ng FIV gag-specific oligonucleotides and PCR-analysis
roviral gene sequences could be detected ex vivo in
icroglial cells of animals which had been inoculated
ith FIV strains “Wo” and “Bourguignon” (Bour), respec-
ively, 20 months previously (Fig. 4). Interestingly, a two-
tep amplification reaction was needed to uncover len-
iviral DNA, although a large amount (1 3 107) of cells
were used for nucleic acid extraction implying a low copy
number of FIV in CNS parenchyma during the asymp-
tomatic phase of the infection.
In order to investigate if in vivo-infected microglia can
produce infectious virus, brain-resident macrophages
FIG. 1. Expression of the leukocyte common antigen on microglial
cells and peripheral leukocytes. Hemopoietic cells isolated from brain,
lung, and spleen were immunostained for CD45 and analyzed by flow
cytometry.derived from FIV-infected cats were cultured over a pe-
i422 HEIN ET AL.riod of 5 weeks. Every second day, tissue culture super-
natants were removed and monitored for virion-associ-
ated RT activity. However, at no time point past explana-
tion did any of the CNS cell cultures examined disclose
detectable retroviral replication (data not shown). Only
when extracted brain cells were cocultivated with unin-
fected phytohemagglutinin (PHA) activated PBMC could
significant amounts of infectious virus be recovered (Fig.
5). In both, FIV Wo- and Bour-infected cocultures, lenti-
viral production was detectable as soon as 6 days of
culture (doc). Subsequently, lymphocyte cocultivation of
FIV Wo-infected microglia yielded in massive virion re-
lease that remained at high levels throughout the whole
period of observation. Compared to FIV Wo, replication
activity of strain Bour in microglia/PBMC cocultures was
not only slightly delayed but maximal titers of cell-free
virus were significantly lower. Moreover, peak FIV Bour
production at 14 doc was followed by continuous de-
crease of retroviral replication to undetectable levels,
indicating a destructive cytopathogenic effect of this viral
isolate.
It is of note that cocultures of PHA-activated PBMC
and microglia explanted from uninfected animals never
FIG. 2. Cytofluorographic analysis of microglial cells isolated from
sotype-matched control antibodies.revealed RT activity in cell-free supernatants. This makesit unlikely that RT activity recovered from microglia of
FIV-infected cats was due to other feline retroviruses
except for FIV. However, in order to unequivocally at-
tribute extracellular RT activity to the presence of FIV we
performed RT-PCR experiments on supernatants of mi-
croglia/PBMC cocultures. Applying oligonucleotide prim-
ers complementary to the FIV gag region FIV genomes
were demonstrable in FIV Wo- and Bour-infected but not
in uninfected brain cell cultures at 16 doc (Fig. 6) con-
firming our findings using the RT assay as a readout
system for FIV replication. Therefore, it was concluded
that FIV was recovered by lymphocytic cocultivation of
microglial cells from FIV-infected cats.
Detection of FIV antigen in microglial cells following
extraction from infected cat brain
The requirement for nested PCR together with the
need for cocultivation with PHA blasts in order to unravel
FIV in explanted brain cells indicated the presence of
only a few virally infected cells. Taking into account that
approximately 5% of isolated CNS cells were not of
microglial origin there was still the possibility that the
S of normal adult cats. Dashed lines, cells stained with appropriatethe CNvirus detected was derived from contaminating cells and
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423FIV INFECTION OF FELINE RAMIFIED MICROGLIAnot from brain-resident macrophages. To validate FIV
infection of microglial cells two animals each were inoc-
ulated intravenously by the FIV strains Wo and Womicroglia,
espectively, and 3 months past infection CNS cells were
xtracted and seeded on glass coverslips. Following 6 to
FIG. 3. Phenotypic and virological examination of feline ramified mi
microglial cells extracted from the CNS of a 20-month-old cat at 16 da
ligand. Original magnification 3128. (B and C) Mitogen stimulated PBM
Wo infected for 3 months were immunostained for FIV nucleocapsid exp
conjugate. (D and E) Colocalization of the LDL receptor and FIV p24 i
months p.i. (D) LDL receptor expression; (E) same cells as in (D) staindays of culture cells were double labeled for the FIV aucleocapsid protein p24 as well as the LDL receptor.
BMC isolated from the same animals and lectin stimu-
ated for 7 days in vitro were used as negative (Fig. 3B)
nd positive (Fig. 3C) staining controls, respectively. It is
f note that both PBMC and microglial cells did not show
and PBMC. (A) Low-density lipoprotein receptor staining on cultured
Cells were labeled by uptake of the fluorescent conjugated receptor
ated either from an uninfected cat (B) or an animal experimentally FIV
by a monoclonal antibody. Bound antibody was detected using a FITC
glial cells extracted from the CNS of an FIV Wo-infected animal at 3
viral antigen. (B to E) The white bar in (E) represents 50 mm.croglia
ys p.i.
C isol
ression
n microny virus-specific antigen expression ex vivo (data not
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424 HEIN ET AL.shown) but had to be cultured for several days to un-
cover p241 cells. Percentage of viral antigen positive
microglial cells was assessed by two experienced inves-
tigators, each of them counting at least 1000 randomly
FIG. 4. Detection of proviral gene sequences in microglial cells
isolated from cats experimentally infected by FIV strains Wo and Bour,
respectively. Twenty months after inoculation brain-resident macro-
phages were extracted and assayed ex vivo for retroviral infection
using nested PCR and oligonucleotides located in conserved regions
of FIV gag. PCR primers were chosen to yield in a 452-base-pair
fragment. As a control, microglial cells extracted from the CNS of an
uninfected animal were processed under identical conditions. M, DNA
molecular size marker; bp, base pairs.
FIG. 5. Isolation of FIV from feline microglial cells. Brain-resident
acrophages were extracted from the CNS of experimentally FIV Wo
n )- and FIV Bour (E)-infected cats 20 months past inoculation. Isolated
NS cells were cultured along with uninfected, PHA-activated PBMC
ver a period of 34 days to recover infectious virus. Retroviral replica-
ion was monitored by RT activity in cell-free tissue culture supernatant.
ymphocyte cocultivation of microglial cells derived from an uninfected
nimal ({) served as a negative control. At the time points indicated, RT
ctivity was determined in duplicate and mean values were plotted asbluorescence units versus days of culture.distributed cells. Independent of the inoculated FIV strain
less than 1% (0.64 6 0.24% SEM) of isolated brain mac-
ophages was characterized by colocalization of the LDL
eceptor and FIV p24 antigen (Figs. 3D and 3E). This
uggests that during the asymptomatic phase of the FIV
nfection only a minority of brain-resident macrophages
upports retroviral replication.
DISCUSSION
It is now more than a decade ago that, concomitant
ith the recognition of AIDS, cases of unusual enceph-
lopathy in affected patients were reported (Levy et al.,
985; Snider et al., 1983; Whelan et al., 1983). Initially, this
yndrome was attributed to opportunistic CNS infections
Britton and Miller, 1984; Nielsen et al., 1984) but with the
dentification of HIV as the causative agent of AIDS it
ecame evident that the lentivirus itself might invade the
rain and induce dementia. Despite extensive studies,
owever, it is not yet clear how HIV can exert its delete-
ious effects on cognitive and motor functions as the
umber of retrovirally infected CNS cells seems to be
sually low. Currently, the favored hypothesis is that
irus-infected microglial cells are of central importance
n neuropathogenesis and therefore several experimen-
al models have been established to elucidate the role of
he resident macrophage population in lentiviral enceph-
lopathy. Contrary to model systems based on analysis
f embryonic tissue (Dickson et al., 1991; Dow et al.,
992; Peudenier et al., 1991), in this report we present
ata on adult microglial cells that were extracted from
FIG. 6. Detection of extracellular FIV genomes in microglia/PBMC
cocultures. Microglial cells of FIV Wo- and Bour-infected cats were
cultivated together with PHA-activated PBMC. At 16 doc, total RNA was
extracted from cell-free supernatants before being transcribed and
amplified in a PCR using oligonucleotide primers corresponding to the
FIV gag region. Primers were selected to give a PCR product of 791
ase pairs in size. Supernatants of lymphocyte blasts cocultivated with
icroglial cells from an uninfected animal and FIV Villefranche (Vfr)
ontaining stock solution were used as negative and positive controls,
espectively. M, DNA molecular size marker; bp, base pairs.rain parenchyma of domestic cats. In line with previ-
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425FIV INFECTION OF FELINE RAMIFIED MICROGLIAously published observations in various species includ-
ing man (Brinkmann et al., 1992, 1993; Sedgwick et al.,
1991), feline ramified microglia can be unequivocally
defined by its CD45low phenotype indicating a common
feature of brain-resident macrophages. Unlike human
and simian, however, cat microglia do not express the
feline homolog of CD4, representing the primary receptor
for HIV. In view of the fact that microglial cells derived
from the CNS of FIV infected cats express retroviral
antigens, susceptibility to FIV infection appears to be
CD4 independent as it has been shown for a range of
CD42 cell populations (Brunner and Pedersen, 1989;
nglish et al., 1993). More recently, He and colleagues
ave postulated that CCR3 and CCR5 are of key impor-
ance in HIV-1 infection of CNS resident macrophages
He et al., 1997). Since FIV, like HIV, uses chemokine
eceptors for target cell invasion (Poeschla and Looney,
998; Willett et al., 1997, 1998), one might speculate that
these cell surface molecules mediate FIV entry into mi-
croglial cells in the absence of the CD4 antigen. This
hypothesis is supported by preliminary data from our
laboratory indicating expression of several chemokine
receptors on cat microglia.
It is generally accepted that microglia not only repre-
sents the principal lentiviral target in CNS tissue but also
plays a crucial role as antigen-presenting cell in intrace-
rebral immune reactions (Thomas, 1992). In this context,
constitutive MHC class II expression on resident micro-
glia from cat brain is of particular interest since several
important consequences may result from interaction be-
tween microglial cells and brain-infiltrating CD41 T lym-
phocytes: (i) lentiviral infection might be transferred from
immigrating infected CD41 T cells to uninfected micro-
glia similar to the currently favored Trojan horse hypoth-
esis assuming that affected monocytes transport virus
through the blood–brain barrier (Haase, 1986); (ii) in the
SIV monkey model it has been documented that infected
macrophages can fuse with and probably lyse activated
CD41 T lymphocytes and that this fusion process is
accompanied by release of significant amounts of poten-
tially neurotoxic TNFa (McEntee et al., 1992; Soliven and
Albert, 1992); (iii) Erfle and colleagues (1991) have previ-
ously shown that cocultivation with T lymphocytes is
required to rescue infectious virus from persistently
HIV-1 infected glial cell lines (Erfle et al., 1991). Similarly,
our results demonstrate immediate onset of retroviral
production in microglial cells derived from FIV-infected
cats if cultivated together with mitogen-stimulated
PBMC. In the absence of T lymphocyte blasts, however,
virion release from infected microglia was considerably
reduced (data not shown). So far, the nature of the trig-
gering event on viral replication is unknown. Strong clus-
tering and adhesion of PBMC to microglial cells (data not
shown) suggest intimate interactions between both cell
types. Since allogeneic PBMC were used for cocultiva-
tion experiments T cell antigen receptor (TCR)/MHC en-
gagement comparable to a mixed lymphocyte reactionand/or T cell cytokines might play a key role in activation
of proviral gene sequences probably by activation/induc-
tion of NF-kB sites in viral LTR (Folks et al., 1987; Osborn
et al., 1989; Poli and Fauci, 1992). Whatever the exact
activation mechanism will be, our data favor the idea that
microglia/T lymphocyte interaction may promote lentivi-
ral replication, thereby supporting viral dissemination in
CNS tissue.
It is worth mentioning that viruses derived from FIV-
infected microglia exhibited variable cytopathogenic ef-
fects for target cells ranging from manifestation of a
persistent infection on a high replicative level (strain Wo)
to induction of cell lysis (strain Bour). These different
growth properties might be explained by the source of
viruses used for inoculation of animals. Whereas the
strain Wo was originally obtained from an animal with
clinically overt signs of terminal immunodeficiency, FIV
Bour was isolated from an asymptomatic cat. From that
one might assume that, similar to HIV, progression of FIV
infection is accompanied by changes in viral tropism
and/or host cell permissiveness.
One of the most intriguing aspects of immunodefi-
ciency virus-induced encephalopathy is the relationship
of intracerebral virus load to the development of neuro-
pathology. Usually, less than 5% of brain-resident mac-
rophages contain proviral DNA in HIV-1-infected individ-
uals without overt CNS disease with an even lower
number of virus replicating microglial cells, ranging be-
tween 0 and 3% (Nouvo et al., 1994; Bagasra et al., 1996).
In line with these and other data from the SIV (Boche et
al., 1999) as well as the FIV model (Boche et al., 1996) we
found that as few as 0.6% of microglial cells displayed
retroviral antigen expression in FIV affected CNS at 3
months past infection even though the percentage of FIV
DNA-positive brain macrophages will be probably
higher. Interestingly, FIV p241 microglial cells were not
detectable ex vivo but only after short-term in vitro cul-
ture. Obviously, a triggering signal like adherence to the
tissue culture support is required for induction of viral
antigen expression as it has been recently discussed for
monocytes from FIV-infected animals (Dow et al., 1999).
This suggests that during the asymptomatic stage of
lentiviral CNS infections virus replication in infected mi-
croglial cells is either absent or at least a very rare event.
Nevertheless, marked CNS lesions and neurological ab-
normalities are detectable already during the early
phase of HIV and FIV infection (Henriksen et al., 1995),
supporting the widely accepted hypothesis that virus-
induced but indirect mechanisms may be responsible for
brain injury.
Taken together the presented data underline the im-
portance of ramified microglial cells as retroviral reser-
voir in FIV-infected brain. In view of the similarities be-
tween FIV- and HIV-induced CNS disease the FIV model
will allow comprehensive studies on the relationships
between microglia and lentivirus-induced encephalopa-
thy that cannot be studied in man.
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426 HEIN ET AL.MATERIALS AND METHODS
Animals
Specific pathogen-free (SPF) cats of the strain ICo:Fec
Eur, Tif, were purchased from IFFA-CREDO (Lyon,
France) and housed under sterile conditions at the Viro-
logical Department of the Strasbourg University, France.
At 6 months of age, they were either infected intrave-
nously by injection of cell-free tissue culture superna-
tants containing 0.5 3 106 cpm reverse transcriptase (RT)
nits of FIV strain Wo (kind gift of A. Moraillon, E´cole
e´te´rinaire, Maison d’Alfort, France), 0.5 3 106 cpm RT
nits of strain Womicroglia, and 4.0 3 10
6 cpm RT units of the
IV isolate Bour, respectively, or left untreated as nega-
ive controls. Animals were sacrificed at 3 or 20 months
ostinoculation (p.i.) and immediately necropsied.
iruses
The FIV strains Wo and Bour were isolated from PBMC
f naturally infected cats by cocultivating with mitogen-
timulated blood leukocytes from SPF donors. Strain
illefranche (Vfr; IFFA 1/88) was from IFFA Rhoˆne
e´rieux and propagated in chronically infected IRC4
eline kidney cells (IFFA Rhoˆne Me´rieux). Following
5–20 days of cultivation cell-free tissue culture super-
atants were collected and assayed for virion-associ-
ted RT activity. Strain Womicroglia was recovered from
microglial cells derived from an experimentally FIV Wo-
infected animal by culturing together with uninfected
PHA blasts for 10–18 days followed by one additional
passage over PBMC for 12 days. Infectious virus stocks
were adjusted to 0.5 2 2 3 106 cpm/ml RT activity and
stored in aliquots at 280°C.
Isolation of microglial cells
Microglial cells were extracted from feline CNS ac-
cording to a method previously described by Sedgwick
et al. (1991) and Brinkmann et al. (1993) with slight mod-
ifications. At necropsy, brain was removed and trans-
ferred immediately in ice-cold Hank’s buffered salt solu-
tion (HBSS; Biochrom, Berlin, Germany) supplemented
with 3% (vol/vol) fetal calf serum (FCS; PAA, Co¨lbe, Ger-
many). After being meninges-stripped, 20 g of CNS tis-
sue was minced through a stainless-steel sieve with the
plunger of a 20-ml syringe. The dissociated material was
divided into 5-g portions, sedimented (170 g, 4°C, 10 min)
and subjected to enzymatic digestion in a mixture of
0.78% (wt/vol) collagenase (Serva, Heidelberg, Germany)
and 400 Units (U) of DNAse I (Boehringer Mannheim,
Germany)/g tissue in dissociation buffer (for details see
(Sedgwick et al., 1991)) at 37°C for 60 min. Digested CNS
was washed once with HBSS (170 g, 4°C, 10 min) and
resuspended in 25 ml HBSS-buffered isotonic Percoll
(Amersham Pharmacia Biotech, Uppsala, Sweden) at
1048 g cm23 to give a final density of 1030 g cm23. This
suspension was underlayered by a 5-ml Percoll cushion fat 1088 g cm23 and overlayered by 5 ml HBSS/3% FCS.
Following 20 min centrifugation at 1250 g, 20°C (accel-
eration time 30 s, deceleration time 5 min), the 1030 g
cm23/1088 g cm23 interface was collected and overlay-
ered onto a second gradient consisting of four density
steps with 9 ml each of Percoll at 1088, 1072, 1060, and
1050 g cm23. After centrifugation (1250 g, 20°C, 20 min)
icroglial cells were recovered from the top of the 1060
nd 1072 g cm23 interfaces, washed once in HBSS (170
g, 4°C, 10 min), and resuspended in complete growth
medium (CGM), i.e., RPMI 1640 (Biochrom, Berlin, Ger-
many) supplemented with 5% (vol/vol) FCS, 2 mM L-
lutamin, 2 mM sodium pyruvate, nonessential amino
cids, 100 U ml21 penicillin, 100 mg of streptomycin (all
rom Biochrom, Berlin, Germany), and 50 mM 2-mercap-
toethanol (Merck, Darmstadt, Germany). Trypan blue
negative cells were counted, seeded in a 24-well cluster
plate (Greiner, Nu¨rtingen, Germany) at 1 3 106 cells/well
n 0.5 ml CGM, and cultured at 37°C in a humidified
tmosphere containing 5% CO2. Total number of extract-
able cells per CNS was calculated as mean value 6
standard error of the mean (sem).
Isolation of spleen cells and broncho-alveolar
macrophages
Single spleen cell suspensions were obtained apply-
ing standard tissue preparation techniques. In brief,
spleen was mechanically disrupted in icecold HBSS/3%
FCS followed by separation of undissociated tissue frag-
ments by gravity sedimentation (5 min, 4°C). After col-
lection from supernatant (170 g, 4°C, 10 min) cells were
resuspended in 10 ml lysis buffer (155 mM NH4Cl, 10 mM
HCO3, 0.01 mM EDTA) and incubated for 8 min at
7°C/5% CO2 to remove contaminating erythrocytes. Re-
maining spleenocytes were washed once (170 g, 4°C, 10
min) and subjected to cytofluorographic analysis.
For isolation of bronchoalveolar (BAL) macrophages
50 ml phosphate-buffered saline (PBS; 4°C) was inocu-
lated into the lung via the tracheal route using a plastic
feeding tube with lateral eyes (Braun, Melsungen, Ger-
many). Following a 10-min incubation period PBS was
aspirated and cells were recovered by low-speed cen-
trifugation (170 g, 4°C, 10 min) to be used in flow cytom-
try.
onoclonal and polyclonal antibodies
Microglial cells were phenotypically characterized us-
ng the following mouse monoclonal antibodies (mabs)
nd polyclonal IgG fractions: mabs fCD4 (anti-feline CD4)
nd f43 (anti-feline CD5) were obtained from Southern
iotechnology Associates (Birmingham, England). Anti-
eline CD8 (clone vpg9), anti-feline CD9 (clone vpg15),
nti-human CD40 (clone B-B20; cross-reactive with the
eline homolog), anti-feline CD45 (clone WC45a), anti-
heep MHC class I (clone vpm19; cross-reactive witheline MHC I), and anti-feline MHC class II (clone vpg3)
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427FIV INFECTION OF FELINE RAMIFIED MICROGLIAwere purchased from Serotec (Oxford, England). Anti-
human CD18, also recognizing the b-chain of the feline
LFA-1, and polyclonal anti-GFAP were from Dako
(Glostrup, Denmark). The mab used for detection of FIV
nucleocapsid protein p24 was a kind gift of Rhoˆne
Me´rieux (France). Rabbit anti-Gal C was purchased from
Sigma (Deisenhofen, Germany). Normal mouse IgG stan-
dard (Southern Biotechnology Associates, Birmingham,
England) and normal rabbit IgG (Dianova, Hamburg, Ger-
many) served as isotype controls. Primary mabs and
rabbit sera were detected by fluorescence-labeled goat
anti-mouse, goat anti-rabbit immunoglobulin (both from
Dianova, Hamburg, Germany), and streptavidin-RED670
(GibcoBRL, Eggenstein, Germany), respectively.
Cell labeling and flow cytometry
Expression of the LDL receptor was investigated with
DiI-Ac-LDL from Paesel1Lorei (Hanau, Germany) ac-
cording to the manufacturer’s recommendations. GFAP
and Gal C were stained on seeded microglial cells after
methanol/aceton (1:2, 4°C, 2 min) fixation. FIV p24 was
detected either ex vivo on PBMC and brain cells spotted
onto microscope slides or following 7 days culture in the
case of PBMC and 6 to 7 days culture on glass cover
slides in the case of microglial cells and methanol/
aceton fixation. When coexpression of LDL receptor and
FIV nucleocapsid protein was investigated cells were
first labeled by DiI-Ac-LDL before being formaldehyde
fixed (1% in PBS, 4°C, 30 min). First antibodies were
added and incubated for 60 min at room temperature.
Cells were washed three times for 5 min each with PBS
before addition of FITC-goat F(ab9)2 anti-rabbit IgG (H 1
) and FITC-goat F(ab9)2 anti-mouse IgG (H 1 L), respec-
tively. Fluorescent staining of cells was examined with a
Leica DMRB microscope. For cytofluorographic analysis,
cells (2 3 105) were incubated with mabs in a total
olume of 100 ml on ice for 20 min. To reduce background
staining 10% heat-inactivated normal cat serum was in-
cluded in the staining buffer. After a washing step (400 g,
4°C, 5 min) bound mabs were detected (20 min, 4°C) in
the dark by FITC-conjugated goat anti-mouse IgG or
streptavidin-RED670 if a biotinylated primary mab was
applied. Subsequently, cells were washed (400 g, 4°C, 5
min) and assessed on a FACScan flow cytometer (Becton
& Dickinson, Heidelberg, Germany). In the case of dual-
labeling, indirect immunostaining was followed by satu-
ration of conjugate-associated free binding sites by 20%
normal mouse serum before addition of fluorescent la-
beled secondary mab. Data from 10,000 live-gated cells
were acquired and analyzed using the CellQuest soft-
ware package Version 1.0 and a Power MacIntosh 7600
computer.
PCR
Genomic DNA from microglial cells was isolated by
affinity chromatography using a high pure PCR template gpreparation kit (Boehringer Mannheim, Germany). Ex-
tracted DNA from 1 3 107 cells was dissolved in nucle-
ase-free water and stored at 220°C. To detect proviral
gene sequences a 452-base-pair (bp) fragment from the
FIV gag region was amplified in a nested PCR. PCR
primers were designed according to previously pub-
lished sequences of the FIV-Petaluma strain with aid of
OLIGO software, Version 5.0. The outer primers were
59-ACACTAGGCCATCTATGAAAG-39 (gag gene position
974–994) and 59-ATTAAAACACACTGGTCCTGA-39 (posi-
tion 1744–1764). The inner primer set corresponded to
59-CAGAATATGATCGCACACATC-39 (position 1262–1282)
and 59-AAGAGCTTCTGCCAAGAGTT-39 (position 1694–
1713). The first round of amplification was carried out in
a total volume of 50 ml containing 5 ml DNA, 10 mM
ris/HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 200 mM of
each dNTP, 20 pmol of each outer primer, 0.2 U inorganic
pyrophosphatase (eurobio, Les Ulis Cedex B, France),
and 2 U Taq polymerase. PCR was run on the RoboCy-
cler Gradient 96 (Stratagene, Amsterdam, The Nether-
lands) with denaturing for 2 min at 94°C, followed by 40
cycles of 94°C for 1 min, 46°C for 1 min, and 72°C for 1.5
min, with a final extension of 10 min at 72°C. For the
second round of amplification, PCR was performed in a
50-ml volume using 10 ml of the first amplification product
with 40 pmol each of the internal primer pair for 40 cycles
(92°C, 1 min; 50°C, 1 min; 72°C, 1 min) preceded by a
primary denaturation step of 3 min at 92°C and com-
pleted by 10 min extension at 72°C. PCR products (20 ml)
were analyzed by electrophoresis through 1.2% agarose
gels containing 0.5 mg/ml ethidium bromide. If not oth-
erwise stated, PCR reagents were obtained from Boehr-
inger (Mannheim, Germany).
RT-PCR
For detection of FIV genomes in microglia/PBMC co-
cultures RNA was extracted from cell-free supernatants
applying the QIAmp viral RNA kit (Qiagen, Hilden, Ger-
many). Tissue culture supernatants of FIV Vfr infected
IRC4 feline kidney cells served as positive controls. A
1-mg sample of DNAseI-treated (15 min, 37°C) nucleic
cid was reverse transcribed (first strand cDNA synthe-
is kit, Boehringer Mannheim, Germany) before running
PCR in the presence of FIV gag primers at positions
74–994 and 1744–1764 using the same cycling condi-
ions as for the amplification of proviral FIV gene se-
uences in explanted microglial cells.
IV recovery from microglial cells and RT assay
FIV was isolated from in vivo-infected microglia by
ocultivation with Ficoll purified PBMC from healthy do-
ors. PBMC (2 3 106/ml) had been stimulated before by
incubating in CGM supplemented with 5 mg ml21 PHA
Amersham Pharmacia Biotech, Uppsala, Sweden) for 3
ays. Thereafter, blast cells were collected by centrifu-
ation (13,000 g, 20°C, 20 min) through a discontinuous
1I
d
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in HBSS) and mixed in equal numbers with freshly pre-
pared microglial cells from FIV-infected cats. Then 1 3
06 cells were seeded per well of a 24-well cluster plate
in 1 ml CGM containing 200 U ml21 recombinant human
L-2 (R&D Systems, Wiesbaden, Germany). Every second
ay, tissue culture supernatants (750 ml) were replaced
and monitored for retroviral propagation by determina-
tion of cell-free RT activity. For quantification of retrovirus
progeny a commercially available assay was used (re-
verse-transcriptase assay, nonradioactive, Boehringer,
Mannheim, Germany) essentially following the kit in-
structions, but with some slight modifications. In brief,
samples were lysed without further enrichment of viral
particles and mixed with reaction buffer to allow
oligo(dT) primed reverse transcription for 15 h at 37°C.
Synthesized digoxigenin (DIG)-labeled cDNA was de-
tected by a DIG-specific polyclonal IgG fraction from
sheep conjugated to alkaline phosphatase (AP) and the
Attophos substrate (both from Boehringer, Mannheim,
Germany). AP-induced fluorochrome formation was mea-
sured in a FluoroskanII fluorometer (Labsystems, Hel-
sinki, Finland) at 444 nm excitation and 555 nm emission.
Nucleotide sequence accession numbers
The nucleic acid sequence used for the design of FIV
gag-specific PCR primers was obtained from GenBank.
The complete sequence of the FIV-Petaluma strain was
listed under Accession No. M25729.
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